Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Eukaryon recombinant plasmid, preparation process and applications thereof

A recombinant plasmid and eukaryotic technology, applied in the field of genetic engineering, can solve the problem of undiscovered oncogenes and tumor suppressor genes, and achieve the effect of promoting development and benefiting rehabilitation

Inactive Publication Date: 2012-08-22
SICHUAN UNIV
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Human laryngeal squamous cell carcinoma is a common malignant tumor, and now some oncogenes (such as survivin, c-myc, Bcl-2, etc.) and tumor suppressor genes (such as p53, DCC, nm23, APC, PTEN, DPC4, etc.) have been discovered , the oncogenes and tumor suppressor genes are closely related to the occurrence and development of human laryngeal squamous cell carcinoma, but so far there are still many oncogenes and tumor suppressor genes that have not yet been discovered

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Eukaryon recombinant plasmid, preparation process and applications thereof
  • Eukaryon recombinant plasmid, preparation process and applications thereof
  • Eukaryon recombinant plasmid, preparation process and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1: Preparation of eukaryotic recombinant plasmid pGPU6 / GFP / Neo / CY-FBXL20

[0035] 1. Synthesis of oligonucleotides

[0036] The loop structure in the shRNA template uses TTCAAGAGA to avoid the formation of a termination signal, and the shRNA transcription termination sequence adopts the T6 structure. CACC is added to the 5' end of the sense strand template, which is complementary to the sticky end formed after digestion with BbsI; GATC is added to the 5' end of the antisense strand template, which is complementary to the sticky end formed after digestion with BamHI; if the first siRNA If a base is not G, add a G after CACC.

[0037] The target sequence is 5-CCAAATGCTTAGCCAATCT-3, the complementary strand is 3-AGATTGGCTAAGCATTTGG-5; the sense strand of the target sequence is 5- CACCG CCAAATGCTTAGCCAATCT TTCAAGAGA AGATTGGCTAAGCATTTGG TTTTTTG -3,

[0038] The target sequence antisense strand is 5- GATCCAAAAAA CCAAATGCTTAGCCAATCT TCTCTTGAA AGATTGGCTAAGCA...

Embodiment 2

[0060] Example 2: Activity determination of eukaryotic recombinant recombinant plasmid pGPU6 / GFP / Neo / CY-FBXL20

[0061] 1. Cell culture

[0062] DMEM high-glucose medium (purchased from Gbico) with a volume concentration of fetal bovine serum of 10% was used at 37° C., 5% CO 2 The laryngeal squamous cell carcinoma Hep2 cell line (purchased from ATCC, USA) was cultured in a cell culture incubator until the culture flask was confluent.

[0063] 2. Transfection of Hep2 cells

[0064] 2.1 Inoculate 1 / 24 laryngeal squamous cell carcinoma Hep2 cells in each well of a 24-well cell culture plate;

[0065] 2. After 224 hours, discard the original medium, and add 0.4ml of serum-free and antibiotic-free DMEM high-glucose medium;

[0066] 2.3A solution preparation: 1μg eukaryotic recombinant plasmid pGPU6 / GFP / Neo / CY-FBXL20+50μl DMEM culture medium;

[0067] Solution B preparation: 2.5 μl Lipo2000 (SIGMA company) + 50 μl DMEM culture solution;

[0068] Preparation of liquid C: After s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A eukaryon recombinant plasmid is constructed by a eukaryotic vector and a CY-FBXL20 segment in the nucleotide sequence of human FBXL20 gene shown in SEQ ID NO.1 in a sequence table, and the CY-FBXL20 segment is a nucleotide sequence from 10045bp to 10063bp in initiator codon downstream. A preparation process of the eukaryon recombinant plasmid comprises the following steps of firstly, obtaining an RNAi segment of the CY-FBXL20 segment in the human FBXL20 gene by means of a ribonucleic acid (RNA) solid phase synthesis method; secondly, inserting the RNAi segment with respective restriction enzyme cutting sites of BamI and BbsI of the CY-FBXL20 segment into the eukaryotic vector to construct the eukaryon recombinant plasmid, transforming the eukaryon recombinant plasmid into competence bacteria for culturing, and screening out clones containing correct inserted segments; and thirdly, extracting the constructed eukaryon recombinant plasmid by means of an alkaline lysis method, analyzing the constructed eukaryon recombinant plasmid by means of a restriction enzyme restriction enzyme map, and performing deoxyribonucleic acid (DNA) sequence analysis. The eukaryon recombinant plasmid can be applicable to the preparation of drugs for curing laryngeal squamous cell carcinoma.

Description

technical field [0001] The invention belongs to the field of genetic engineering, and particularly relates to a eukaryotic recombination plasmid, a preparation method thereof and an application in preparation of medicine for treating laryngeal squamous cell carcinoma. Background technique [0002] In recent years, the threat of malignant tumors to humans has become increasingly prominent, and tumors have become one of the common causes of death, seriously affecting human health. Human laryngeal squamous cell carcinoma is a common malignant tumor, and now some oncogenes (such as survivin, c-myc, Bcl-2, etc.) and tumor suppressor genes (such as p53, DCC, nm23, APC, PTEN, DPC4, etc.) have been discovered , the oncogenes and tumor suppressor genes are closely related to the occurrence and development of human laryngeal squamous cell carcinoma, but there are still many oncogenes and tumor suppressor genes that have not been discovered so far. [0003] The human FBXL20 gene has b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/79C12N15/12C12N15/66A61K48/00A61P35/00
Inventor 陈尧朱剑军
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com